Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma

American Journal of Surgical Pathology

Volumn 38, Issue 6, 2014, Pages 801-808

  Arbajian, Elsa ^a   Puls, Florian ^b   Magnusson, Linda ^a   Thway, Khin ^c   Fisher, Cyril ^c   Sumathi, Vaiyapuri P ^b   Tayebwa, Johnbosco ^a   Nord, Karolin H ^a   Kindblom, Lars Gunnar ^b   Mertens, Fredrik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

CREB3L1; CREB3L2; EWSR1; FUS; Gene fusion; Hybrid; Low grade fibromyxoid sarcoma; Sclerosing epithelioid fibrosarcoma

Indexed keywords

CALMODULIN BINDING PROTEIN; CREB3L1 PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EWSR1 PROTEIN, HUMAN; MESSENGER RNA; MUC4 PROTEIN, HUMAN; MUCIN 4; NERVE PROTEIN; RNA BINDING PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CHEMISTRY; COMPARATIVE STUDY; EPITHELIOID CELL; FEMALE; FIBROMA; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE REARRANGEMENT; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLEROSIS; SEQUENCE ANALYSIS; SOFT TISSUE TUMOR; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CALMODULIN-BINDING PROTEINS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EPITHELIOID CELLS; FEMALE; FIBROMA; FIBROSARCOMA; GENE FUSION; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MUCIN-4; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NERVE TISSUE PROTEINS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEIN FUS; RNA-BINDING PROTEINS; SCLEROSIS; SEQUENCE ANALYSIS, RNA; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84900789796     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000158     Document Type: Article

References (39)

1. Kindblom LG, Mertens F, Coindre JM, et al. Sclerosing epithelioid fibrosarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, et al, eds. WHO classification of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2013:97-98
2. Meis-Kindblom JM, Kindblom LG, Enzinger FM. Sclerosing epithelioid fibrosarcoma A variant of fibrosarcoma simulating carcinoma. Am J Surg Pathol. 1995;19:979-993
3. Antonescu CR, Rosenblum MK, Pereira P, et al. Sclerosing epithelioid fibrosarcoma: A study of 16 cases and confirmation of a clinicopathologically distinct tumor. Am J Surg Pathol. 2001;25:699-709
4. Folpe AL, Lane KL, Paull G, et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: A clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol. 2000; 24:1353-1360
5. Guillou L, Benhattar J, Gengler C, et al. Translocation-positive lowgrade fibromyxoid sarcoma: Clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: A study from the French Sarcoma Group. Am J Surg Pathol. 2007;31:1387-1402
6. Lane KL, Shannon RJ, Weiss SW. Hyalinizing spindle cell tumor with giant rosettes: A distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am J Surg Pathol. 1997;21:1481-1488
7. Rekhi B, Folpe AL, Deshmukh M, et al. Sclerosing epithelioid fibrosarcoma-A report of two cases with cytogenetic analysis of FUS gene rearrangement by FISH technique. Pathol Oncol Res. 2011;17:145-148
8. Evans HL. Low-grade fibromyxoid sarcoma: A report of 12 cases. Am J Surg Pathol. 1993;17:595-600
9. Panagopoulos I, Storlazzi CT, Fletcher CDM, et al. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer. 2004;40:218-228
10. Mertens F, Fletcher CDM, Antonescu CR, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005;85:408-415
11. Lau PPL, Lui PCW, Lau GTC, et al. EWSR1-CREB3L1 gene fusion: A novel alternative molecular aberration of low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2013;37:734-738
12. Doyle LA, Wang WL, Dal Cin P, et al. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: Association with FUS gene rearrangement. Am J Surg Pathol. 2012; 36:1444-1451
13. Reid R, de Silva MV, Paterson L, et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am J Surg Pathol. 2003; 27:1229-1236
14. Wang WL, Evans HL, Meis JM, et al. FUS rearrangements are rare in "pure" sclerosing epithelioid fibrosarcoma. Mod Pathol. 2012;25:846-853
15. Doyle LA, Möller E, Dal Cin P, et al. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2011;35:733-741
16. Kim D, Pertea G, Trapnell C, et al. TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36
17. Williams A, Bartle G, Sumathi VP, et al. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffinembedded tissue in a series of 18 cases of alveolar soft part sarcoma: Useful diagnostic tools in cases with unusual histological features. Virchows Arch. 2011;458:291-300
18. Jin Y, Möller E, Nord KH, et al. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosomes Cancer. 2012;51:510-520
19. Evans HL. Low-grade fibromyxoid sarcoma A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987;88:615-619
20. Gisselsson D, Andreasson P, Meis-Kindblom JM, et al. Amplification of 12q13 and 12q15 sequences in a sclerosing epithelioid fibrosarcoma. Cancer Genet Cytogenet. 1998;107:102-106
21. Ogose A, Kawashima H, Umezu H, et al. Sclerosing epithelioid fibrosarcoma with der(10)t(10;17)(p11;q11). Cancer Genet Cytogenet. 2004;152:136-140
22. Evans HL. Low-grade fibromyxoid sarcoma: A clinicopathologic study of 33 cases with long-Term follow-up. Am J Surg Pathol. 2011; 35:1450-1462
23. Riggi N, Cironi L, Suva ML, et al. Sarcomas: Genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol. 2007; 213:4-20
24. Mitelman F, Johansson B,Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer. 2007;7:233-245
25. Bertolotti A, Melot T, Acker J, et al. EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: Interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol Cell Biol. 1998;18:1489-1497
26. Bertolotti A, Lutz Y, Heard DJ, et al. hTAF(II)68, a novel RNA/ ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 1996;15:5022-5031
27. Lee J, Rhee BK, Bae GY, et al. Stimulation of Oct-4 activity by Ewing's sarcoma protein. Stem Cells. 2005;23:738-751
28. Powers CA, Mathur M, Raaka BM, et al. TLS (translocated-inliposarcoma) is a high-Affinity interactor for steroid, thyroid hormone, and retinoid receptors. Mol Endocrinol. 1998;12:4-18
29. Rappsilber J, Ryder U, Lamond AI, et al. Large-scale proteomic analysis of the human spliceosome. Genome Res. 2002;12:1231-1245
30. Zhou Z, Licklider LJ, Gygi SP, et al. Comprehensive proteomic analysis of the human spliceosome. Nature. 2002;419:182-185
31. Hicks GG, Singh N, Nashabi A, et al. Fus deficiency in mice results in Defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet. 2000;24:175-179
32. Kuroda M, Sok J, Webb L, et al. Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. EMBO J. 2000;19:453-462
33. Li H, Watford W, Li C, et al. Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development. J Clin Invest. 2007;117: 1314-1323
34. Fujii R, Takumi T. TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J Cell Sci. 2005;118: 5755-5765
35. Belly A, Moreau-Gachelin F, Sadoul R, et al. Delocalization of the multifunctional RNA splicing factor TLS/FUS in hippocampal neurones: Exclusion from the nucleus and accumulation in Dendritic granules and spine heads. Neurosci Lett. 2005;379:152-157
36. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205-1208
37. Vance C, Rogelj B, Hortobagyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208-1211
38. Kondo S, Hino SI, Saito A, et al. Activation of OASIS family, ER stress transducers, is dependent on its stabilization. Cell Death Differ. 2012;19:1939-1949
39. Straessler KM, Jones KB, Hu H, et al. Modeling clear cell sarcomagenesis in the mouse: Cell of origin Differentiation state impacts tumor characteristics. Cancer Cell. 2013;23:215-227.